Company intelligence / Profile preview

MEVLABS

Savannah, Georgia, USA
Ownership
Private
Development stage
Other
01

Overview

MEVLABS, Inc. is a research and development company specializing in public health solutions, particularly in the field of infectious disease prevention and vector control. The company develops innovative technologies to combat arthropod-borne diseases like malaria and dengue, with a focus on eco-friendly and affordable products. Their flagship technologies include the ProVector® delivery system and Entobac® biocide formulations, which are designed to target disease-carrying insects efficiently. MEVLABS also provides expert consulting, diagnostic testing, and software for infectious disease risk assessment. As a disabled veteran-owned small business, they collaborate with government agencies and international research organizations to implement health interventions globally.

Therapeutic areas
Infectious Diseases
Modalities
DeviceBiocideSmall moleculeMicrobial therapy
Industry
Non-Drug Biotech
02

Partnerships

MIT Holding, Inc.Harris County Public HealthU.S. Army Medical Component-AFRIMS

Beyond the preview

Go deeper on MEVLABS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MEVLABS.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call